Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)

NCT00459446 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00459446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00459446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 1
Overall status
Completed
Start date
April 5, 2007
Completion date
Not reported
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, chronic total aterial occlusion, intermittent claudication, peripheral artery disease